28.17
Precedente Chiudi:
$28.11
Aprire:
$28.24
Volume 24 ore:
341.54K
Relative Volume:
1.01
Capitalizzazione di mercato:
$1.05B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+3.38%
1M Prestazione:
+46.49%
6M Prestazione:
+169.83%
1 anno Prestazione:
+0.61%
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Nome
Oruka Therapeutics Inc
Settore
Industria
Telefono
650-606-7910
Indirizzo
855 OAK GROVE AVE., MENLO PARK
Confronta ORKA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ORKA
Oruka Therapeutics Inc
|
28.17 | 1.36B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-27 | Iniziato | Guggenheim | Buy |
| 2025-10-13 | Iniziato | Barclays | Overweight |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-10-11 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | Leerink Partners | Outperform |
| 2024-09-16 | Iniziato | TD Cowen | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2018-02-27 | Iniziato | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Iniziato | Dawson James | Buy |
Mostra tutto
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Is Oruka Therapeutics Inc. (HQ1) stock undervalued at current price2025 Top Decliners & Safe Swing Trade Setups - newser.com
Is Oruka Therapeutics Inc. stock supported by strong cash flowsTrade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
Will Oruka Therapeutics Inc. stock outperform growth indexes2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Can Oruka Therapeutics Inc. (HQ1) stock hold up in economic slowdownJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
What analysts say about Oruka Therapeutics Inc stockCovered Call Writing & Control Your Emotions With Discipline Tools - earlytimes.in
Why Oruka Therapeutics Inc. stock attracts global investorsEarnings Growth Report & Free Fast Gain Swing Trade Alerts - newser.com
What technical patterns form on Oruka Therapeutics Inc. (HQ1) stock chartsWeekly Trend Report & Low Drawdown Investment Strategies - newser.com
Will Oruka Therapeutics Inc. stock recover faster than marketTrade Volume Summary & High Accuracy Investment Signals - newser.com
Will Oruka Therapeutics Inc. (HQ1) stock return to pre crash levelsJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
Published on: 2025-10-31 04:52:14 - newser.com
Price action breakdown for Oruka Therapeutics Inc.Insider Buying & Verified Entry Point Detection - newser.com
Volume spikes in Oruka Therapeutics Inc. stock – what they meanChart Signals & Consistent Profit Alerts - newser.com
Pattern recognition hints at Oruka Therapeutics Inc. upside2025 Historical Comparison & Reliable Volume Spike Alerts - newser.com
Why retail investors favor Oruka Therapeutics Inc. stock2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Will Oruka Therapeutics Inc. stock go up soonGap Down & Entry and Exit Point Strategies - newser.com
HC Wainwright Brokers Raise Earnings Estimates for ORKA - MarketBeat
Key metrics from Oruka Therapeutics Inc.’s quarterly dataWeekly Gains Summary & Risk Managed Trade Strategies - newser.com
Is Oruka Therapeutics Inc. stock a bargain at current levels2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Q3 EPS Forecast for Oruka Therapeutics Boosted by Analyst - Defense World
Published on: 2025-10-29 21:32:46 - newser.com
Wall Street Analysts Predict a 63.59% Upside in Oruka Therapeutics, Inc. (ORKA): Here's What You Should Know - sharewise.com
Oruka Therapeutics to Present at Multiple November Investor Conferences - The Manila Times
Oruka Therapeutics (NASDAQ:ORKA) Now Covered by Analysts at Guggenheim - Defense World
Oruka Therapeutics’ Promising Psoriasis Study: What Investors Need to Know - TipRanks
Oruka Therapeutics Inc Azioni (ORKA) Dati Finanziari
Non sono disponibili dati finanziari per Oruka Therapeutics Inc (ORKA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):